Cradle Bio Secures $73 Million in Funding to Revolutionize Cell-Factories for a Sustainable Future

Cradle, a pioneering biotech company dedicated to redefining the landscape of production through biological innovation, is thrilled to announce a successful funding round of $73 million. At Cradle, we believe that cells possess the potential to produce a diverse array of products ranging from sustainable fabrics and nutritious food to environmentally friendly fuels and life-saving medicines. Our mission is to accelerate the shift from traditional factories and intensive farming practices to a more sustainable, cell-based manufacturing model. With this latest influx of capital, we intend to further develop our cutting-edge tools and machine-learning models, which simplify the complex process of designing and optimizing cell-factories. This funding will enable us to scale our operations, enhance our research capabilities, and attract top-tier talent all aimed at building the future of production. As we embark on this exciting journey, we remain committed to promoting sustainability and efficiency in manufacturing, ensuring that our advancements not only yield innovative products but also benefit the planet. Cradle is actively hiring, and we invite passionate individuals eager to join our mission to embark on what promises to be a transformative experience in the world of biotech. For those interested in contributing to a more sustainable future, visit our careers page at https://jobs.cradle.bio to explore current opportunities. Together, we can harness the power of biology to revolutionize the way we create and consume.